FDA Issues Severe Warning About Popular Sleep Apnea Machine Risk

Philips faces new FDA scrutiny over life-threatening defects of its DreamStation 2 CPAP.

Dutch electronics giant Philips's stand at Berlin's IFA Consumer Electronics trade fair in Germany on Aug. 31, 2006. John MacDougall/AFP via Getty Images

The FDA warned that Philips’s popular DreamStation 2 CPAP machines, used by millions to treat sleep apnea, pose severe burn risks after the agency received hundreds of incident reports.

The devices have overheated, smoked, and caught fire during use at home and in clinics, resulting in injuries.